Consistent with this result, it has been recently identified that the inhibited TUG1 could restrain the tumor growth of melanoma in vivo12, and Cui et al.45 have demonstrated that miR-187 could inhibit tumor growth in osteosarcoma. Here, TUG1 is linked to melanoma.